Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis

Gloria M. Petersen, Clair Ann Francomano, Kenneth W Kinzler, Yusuke Nakamura

Research output: Contribution to journalArticle

Abstract

The recent identification of the familial adenomatous polyposis (FAP) gene (designated as APC) enables conclusive genetic testing of at-risk family members for the specific mutation in families in which the germline gene mutation has been characterized. Presymptomatic molecular diagnosis of FAP was performed by direct direction of mutations in lymphocyte DNA in four families. Each of the families has a different mutation of the APC gene. Twenty-seven offspring of affected individuals (a priori risk of 50%) were tested. Ten of the 27 had already developed clinical features of FAP. Of the remaining seventeen, two had had a negative colon exam at an early age, and nine had never had colon exams (mean age, 12.1±3.1 SD years). Six children from this group (54%) were found to carry their affected parent's mutation. No change in the conventional FAP colon screening regimen is recommended for these children. In contrast, when direct tests indicate that an individual does not have the FAP mutation, we recommended that screening be decreased. Reduction of uncertainty for at-risk FAP family members is an important benefit of genetic testing.

Original languageEnglish (US)
Pages (from-to)307-311
Number of pages5
JournalHuman Genetics
Volume91
Issue number4
DOIs
StatePublished - May 1993

Fingerprint

APC Genes
Adenomatous Polyposis Coli
Mutation
Genetic Testing
Colon
Germ-Line Mutation
Genes
Uncertainty
Parents
Lymphocytes
DNA

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis. / Petersen, Gloria M.; Francomano, Clair Ann; Kinzler, Kenneth W; Nakamura, Yusuke.

In: Human Genetics, Vol. 91, No. 4, 05.1993, p. 307-311.

Research output: Contribution to journalArticle

@article{8272569d78e84de6ad6d9b16532be10b,
title = "Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis",
abstract = "The recent identification of the familial adenomatous polyposis (FAP) gene (designated as APC) enables conclusive genetic testing of at-risk family members for the specific mutation in families in which the germline gene mutation has been characterized. Presymptomatic molecular diagnosis of FAP was performed by direct direction of mutations in lymphocyte DNA in four families. Each of the families has a different mutation of the APC gene. Twenty-seven offspring of affected individuals (a priori risk of 50{\%}) were tested. Ten of the 27 had already developed clinical features of FAP. Of the remaining seventeen, two had had a negative colon exam at an early age, and nine had never had colon exams (mean age, 12.1±3.1 SD years). Six children from this group (54{\%}) were found to carry their affected parent's mutation. No change in the conventional FAP colon screening regimen is recommended for these children. In contrast, when direct tests indicate that an individual does not have the FAP mutation, we recommended that screening be decreased. Reduction of uncertainty for at-risk FAP family members is an important benefit of genetic testing.",
author = "Petersen, {Gloria M.} and Francomano, {Clair Ann} and Kinzler, {Kenneth W} and Yusuke Nakamura",
year = "1993",
month = "5",
doi = "10.1007/BF00217347",
language = "English (US)",
volume = "91",
pages = "307--311",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis

AU - Petersen, Gloria M.

AU - Francomano, Clair Ann

AU - Kinzler, Kenneth W

AU - Nakamura, Yusuke

PY - 1993/5

Y1 - 1993/5

N2 - The recent identification of the familial adenomatous polyposis (FAP) gene (designated as APC) enables conclusive genetic testing of at-risk family members for the specific mutation in families in which the germline gene mutation has been characterized. Presymptomatic molecular diagnosis of FAP was performed by direct direction of mutations in lymphocyte DNA in four families. Each of the families has a different mutation of the APC gene. Twenty-seven offspring of affected individuals (a priori risk of 50%) were tested. Ten of the 27 had already developed clinical features of FAP. Of the remaining seventeen, two had had a negative colon exam at an early age, and nine had never had colon exams (mean age, 12.1±3.1 SD years). Six children from this group (54%) were found to carry their affected parent's mutation. No change in the conventional FAP colon screening regimen is recommended for these children. In contrast, when direct tests indicate that an individual does not have the FAP mutation, we recommended that screening be decreased. Reduction of uncertainty for at-risk FAP family members is an important benefit of genetic testing.

AB - The recent identification of the familial adenomatous polyposis (FAP) gene (designated as APC) enables conclusive genetic testing of at-risk family members for the specific mutation in families in which the germline gene mutation has been characterized. Presymptomatic molecular diagnosis of FAP was performed by direct direction of mutations in lymphocyte DNA in four families. Each of the families has a different mutation of the APC gene. Twenty-seven offspring of affected individuals (a priori risk of 50%) were tested. Ten of the 27 had already developed clinical features of FAP. Of the remaining seventeen, two had had a negative colon exam at an early age, and nine had never had colon exams (mean age, 12.1±3.1 SD years). Six children from this group (54%) were found to carry their affected parent's mutation. No change in the conventional FAP colon screening regimen is recommended for these children. In contrast, when direct tests indicate that an individual does not have the FAP mutation, we recommended that screening be decreased. Reduction of uncertainty for at-risk FAP family members is an important benefit of genetic testing.

UR - http://www.scopus.com/inward/record.url?scp=0027314363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027314363&partnerID=8YFLogxK

U2 - 10.1007/BF00217347

DO - 10.1007/BF00217347

M3 - Article

VL - 91

SP - 307

EP - 311

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 4

ER -